Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Healthcare Medical Devices
Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Theralase Technologies Inc.
Bullboard Posts
User Avatar Image
(186)
•••
Comment by robertshawon Mar 18, 2019 10:05am
97 Views
Post# 29499851

RE:RE:RE:RE:RE:All that matters is getting TLT over .54 frickn cents!!!

RE:RE:RE:RE:RE:All that matters is getting TLT over .54 frickn cents!!!
robertshaw wrote:
robertshaw wrote:
robertshaw wrote:
chry200030 wrote:
Got a feeling its coming this week.


From the stockcharts.com, you can see the weekly chart, 50 weeks MA is at 0.342, while 200 week MA at 0.346, that said, 50 weeks MA is about to cross 200 weeks MA from the bottom, technically that is called longterm golden MACD cross, which is a long term buying signal. I think this MACD golden cross buying signal will happen today.


I know basementpharkingboy blowjobjoe's pharking boss doesn't want to see this golden cross thing happened, for it's a long term buying signal (guaranteed), but it's not up to these pharking guys, ask the 50 weeks MA is trending up, to cross the 200 weeks MA is about either today or tomorrow, which will bring more new long term investors and new long term buying power and hurry those pharking guys completely.


Weekly chart MACD golden cross just happened this morning, although blowjobjoe 's boss pushed the price down again, But we have no obligation to feed blowjobjoe's pharking boss at even lower price levels..


50week MA at 0.348, 200 week MA still at 0.346...
Bullboard Posts
Dealroom for high-potential pre-IPO opportunities